The long-struggling chain reported better-than-expected revenue for its Q1 2025, although operating losses grew as it plans ...

The U.S. DOJ files lawsuit against Walgreens for dispensing millions of illegal prescriptions, driving shares down 11% in ...

Walgreens Boots Alliance's WBA short percent of float has fallen 19.94% since its last report. The company recently reported ...

The U.S. Justice Department said on Friday it has filed a lawsuit alleging that pharmacy chain operator Walgreens knowingly ...

The US Department of Justice (DOJ) has filed a lawsuit against Walgreens (WBA), one of the nation's largest pharmacy chains, ...

Walgreens Boots Alliance Inc (WBA) stock saw a modest uptick, ending the day at $12.93 which represents a slight increase of $0.40 or 3.19% from the prior close of $12.53. The stock opened at $12.4 ...

Key Insights The projected fair value for Walgreens Boots Alliance is US$24.02 based on 2 Stage Free Cash Flow ...

Walgreens stock surged 27% on Friday, Jan 10, after the company reported upbeat Q1 (fiscal ends in August) results.

Truist Financial analyst Richard Newitter maintained a Hold rating on Walgreens Boots Alliance (WBA – Research Report) today and set a price ...

Walgreens Boots Alliance (NASDAQ:WBA – Get Free Report) had its target price hoisted by equities researchers at Bank of ...

However, ten companies under mixed sectors bucked an overall positive market sentiment as multiple negative factors put pressure on investor sentiment.

The pharmacy chain since August 2012 filled prescriptions that lacked a legitimate medical purpose, were invalid or weren’t issued in professional practice, the Justice Department said.